+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Remicade Biosimilar Global Market Insights 2021, Analysis and Forecast to 2026, by Manufacturers, Regions, Technology, Application, Product Type

  • ID: 5343648
  • Report
  • June 2021
  • Region: Global
  • 106 Pages
  • Prof Research

FEATURED COMPANIES

  • Biocon
  • Biogen idec Inc.
  • Celltrion
  • Genentech (Roche Group)
  • Hospira
  • LG Life Sciences
This report describes the global market size of Remicade Biosimilar from 2016 to 2020 and its CAGR from 2016 to 2020, and also forecasts its market size to the end of 2026 and its CAGR from 2021 to 2026.

For the geography segment, regional supply, demand, major players, price is presented from 2016 to 2026.

This report covers the following regions:
  • North America
  • South America
  • Asia & Pacific
  • Europe
  • MEA
The key countries for each region are also included such as the United States, China, Japan, India, Korea, ASEAN, Germany, France, UK, Italy, Spain, CIS, and Brazil etc.

For competitor segment, the report includes global key players of Remicade Biosimilar as well as some small players.

The information for each competitor includes:
  • Company Profile
  • Business Information
  • SWOT Analysis
  • Revenue, Gross Margin and Market Share
Applications Segment:
  • Blood Disorders
  • Oncology Diseases
Types Segment:
  • 100mg/10ml
  • 500mg/50ml
Companies Covered:
  • Teva Pharmaceutical Industries
  • Synthon Pharmaceuticals
  • LG Life Sciences
  • Novartis (Sandoz)
  • Celltrion
  • Biocon
  • Hospira
  • Merck Serono (Merck Group)
  • Biogen idec Inc.
  • Genentech (Roche Group)
Base Year: 2021
Historical Data: from 2016 to 2020
Forecast Data: from 2021 to 2026
This product will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Biocon
  • Biogen idec Inc.
  • Celltrion
  • Genentech (Roche Group)
  • Hospira
  • LG Life Sciences
Chapter 1 Executive Summary

Chapter 2 Abbreviation and Acronyms

Chapter 3 Preface
3.1 Research Scope
3.2 Research Sources
3.2.1 Data Sources
3.2.2 Assumptions
3.3 Research Method

4. Market Landscape
4.1 Market Overview
4.2 Classification/Types
4.3 Application/End Users

Chapter 5 Market Trend Analysis
5.1 Introduction
5.2 Drivers
5.3 Restraints
5.4 Opportunities
5.5 Threats
5.6 Covid-19 Impact

Chapter 6 Industry Chain Analysis
6.1 Upstream/Suppliers Analysis
6.2 Remicade Biosimilar Analysis
6.2.1 Technology Analysis
6.2.2 Cost Analysis
6.2.3 Market Channel Analysis
6.3 Downstream Buyers/End Users

Chapter 7 Latest Market Dynamics
7.1 Latest News
7.2 Merger and Acquisition
7.3 Planned/Future Project
7.4 Policy Dynamics

Chapter 8 Historical and Forecast Remicade Biosimilar Market in North America (2016-2026)
8.1 Remicade Biosimilar Market Size
8.2 Remicade Biosimilar Market by End Use
8.3 Competition by Players/Suppliers
8.4 Remicade Biosimilar Market Size by Type
8.5 Key Countries Analysis
8.5.1 United States
8.5.2 Canada
8.5.3 Mexico

Chapter 9 Historical and Forecast Remicade Biosimilar Market in South America (2016-2026)
9.1 Remicade Biosimilar Market Size
9.2 Remicade Biosimilar Market by End Use
9.3 Competition by Players/Suppliers
9.4 Remicade Biosimilar Market Size by Type
9.5 Key Countries Analysis
9.5.1 Brazil
9.5.2 Argentina
9.5.3 Chile
9.5.4 Peru

Chapter 10 Historical and Forecast Remicade Biosimilar Market in Asia & Pacific (2016-2026)
10.1 Remicade Biosimilar Market Size
10.2 Remicade Biosimilar Market by End Use
10.3 Competition by Players/Suppliers
10.4 Remicade Biosimilar Market Size by Type
10.5 Key Countries Analysis
10.5.1 China
10.5.2 India
10.5.3 Japan
10.5.4 South Korea
10.5.5 Southest Asia
10.5.6 Australia

Chapter 11 Historical and Forecast Remicade Biosimilar Market in Europe (2016-2026)
11.1 Remicade Biosimilar Market Size
11.2 Remicade Biosimilar Market by End Use
11.3 Competition by Players/Suppliers
11.4 Remicade Biosimilar Market Size by Type
11.5 Key Countries Analysis
11.5.1 Germany
11.5.2 France
11.5.3 United Kingdom
11.5.4 Italy
11.5.5 Spain
11.5.6 Belgium
11.5.7 Netherlands
11.5.8 Austria
11.5.9 Poland
11.5.10 Russia

Chapter 12 Historical and Forecast Remicade Biosimilar Market in MEA (2016-2026)
12.1 Remicade Biosimilar Market Size
12.2 Remicade Biosimilar Market by End Use
12.3 Competition by Players/Suppliers
12.4 Remicade Biosimilar Market Size by Type
12.5 Key Countries Analysis
12.5.1 Egypt
12.5.2 Israel
12.5.3 South Africa
12.5.4 Gulf Cooperation Council Countries
12.5.5 Turkey

Chapter 13 Summary For Global Remicade Biosimilar Market (2016-2021)
13.1 Remicade Biosimilar Market Size
13.2 Remicade Biosimilar Market by End Use
13.3 Competition by Players/Suppliers
13.4 Remicade Biosimilar Market Size by Type

Chapter 14 Global Remicade Biosimilar Market Forecast (2021-2026)
14.1 Remicade Biosimilar Market Size Forecast
14.2 Remicade Biosimilar Application Forecast
14.3 Competition by Players/Suppliers
14.4 Remicade Biosimilar Type Forecast

Chapter 15 Analysis of Global Key Vendors
15.1 Teva Pharmaceutical Industries
15.1.1 Company Profile
15.1.2 Main Business and Remicade Biosimilar Information
15.1.3 SWOT Analysis of Teva Pharmaceutical Industries
15.1.4 Teva Pharmaceutical Industries Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.2 Synthon Pharmaceuticals
15.2.1 Company Profile
15.2.2 Main Business and Remicade Biosimilar Information
15.2.3 SWOT Analysis of Synthon Pharmaceuticals
15.2.4 Synthon Pharmaceuticals Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.3 LG Life Sciences
15.3.1 Company Profile
15.3.2 Main Business and Remicade Biosimilar Information
15.3.3 SWOT Analysis of LG Life Sciences
15.3.4 LG Life Sciences Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.4 Novartis (Sandoz)
15.4.1 Company Profile
15.4.2 Main Business and Remicade Biosimilar Information
15.4.3 SWOT Analysis of Novartis (Sandoz)
15.4.4 Novartis (Sandoz) Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.5 Celltrion
15.5.1 Company Profile
15.5.2 Main Business and Remicade Biosimilar Information
15.5.3 SWOT Analysis of Celltrion
15.5.4 Celltrion Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.6 Biocon
15.6.1 Company Profile
15.6.2 Main Business and Remicade Biosimilar Information
15.6.3 SWOT Analysis of Biocon
15.6.4 Biocon Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.7 Hospira
15.7.1 Company Profile
15.7.2 Main Business and Remicade Biosimilar Information
15.7.3 SWOT Analysis of Hospira
15.7.4 Hospira Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.8 Merck Serono (Merck Group)
15.8.1 Company Profile
15.8.2 Main Business and Remicade Biosimilar Information
15.8.3 SWOT Analysis of Merck Serono (Merck Group)
15.8.4 Merck Serono (Merck Group) Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.9 Biogen idec Inc.
15.9.1 Company Profile
15.9.2 Main Business and Remicade Biosimilar Information
15.9.3 SWOT Analysis of Biogen idec Inc.
15.9.4 Biogen idec Inc. Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
15.10 Genentech (Roche Group)
15.10.1 Company Profile
15.10.2 Main Business and Remicade Biosimilar Information
15.10.3 SWOT Analysis of Genentech (Roche Group)
15.10.4 Genentech (Roche Group) Remicade Biosimilar Revenue, Gross Margin and Market Share (2016-2021)
Please ask for sample pages for full companies list

Tables and Figures
Table Abbreviation and Acronyms
Table Research Scope of Remicade Biosimilar Report
Table Data Sources of Remicade Biosimilar Report
Table Major Assumptions of Remicade Biosimilar Report
Figure Market Size Estimated Method
Figure Major Forecasting Factors
Figure Remicade Biosimilar Picture
Table Remicade Biosimilar Classification
Table Remicade Biosimilar Applications
Table Drivers of Remicade Biosimilar Market
Table Restraints of Remicade Biosimilar Market
Table Opportunities of Remicade Biosimilar Market
Table Threats of Remicade Biosimilar Market
Table Covid-19 Impact For Remicade Biosimilar Market
Table Raw Materials Suppliers
Table Different Production Methods of Remicade Biosimilar
Table Cost Structure Analysis of Remicade Biosimilar
Table Key End Users
Table Latest News of Remicade Biosimilar Market
Table Merger and Acquisition
Table Planned/Future Project of Remicade Biosimilar Market
Table Policy of Remicade Biosimilar Market
Table 2016-2026 North America Remicade Biosimilar Market Size
Figure 2016-2026 North America Remicade Biosimilar Market Size and CAGR
Table 2016-2026 North America Remicade Biosimilar Market Size by Application
Table 2016-2021 North America Remicade Biosimilar Key Players Revenue
Table 2016-2021 North America Remicade Biosimilar Key Players Market Share
Table 2016-2026 North America Remicade Biosimilar Market Size by Type
Table 2016-2026 United States Remicade Biosimilar Market Size
Table 2016-2026 Canada Remicade Biosimilar Market Size
Table 2016-2026 Mexico Remicade Biosimilar Market Size
Table 2016-2026 South America Remicade Biosimilar Market Size
Figure 2016-2026 South America Remicade Biosimilar Market Size and CAGR
Table 2016-2026 South America Remicade Biosimilar Market Size by Application
Table 2016-2021 South America Remicade Biosimilar Key Players Revenue
Table 2016-2021 South America Remicade Biosimilar Key Players Market Share
Table 2016-2026 South America Remicade Biosimilar Market Size by Type
Table 2016-2026 Brazil Remicade Biosimilar Market Size
Table 2016-2026 Argentina Remicade Biosimilar Market Size
Table 2016-2026 Chile Remicade Biosimilar Market Size
Table 2016-2026 Peru Remicade Biosimilar Market Size
Table 2016-2026 Asia & Pacific Remicade Biosimilar Market Size
Figure 2016-2026 Asia & Pacific Remicade Biosimilar Market Size and CAGR
Table 2016-2026 Asia & Pacific Remicade Biosimilar Market Size by Application
Table 2016-2021 Asia & Pacific Remicade Biosimilar Key Players Revenue
Table 2016-2021 Asia & Pacific Remicade Biosimilar Key Players Market Share
Table 2016-2026 Asia & Pacific Remicade Biosimilar Market Size by Type
Table 2016-2026 China Remicade Biosimilar Market Size
Table 2016-2026 India Remicade Biosimilar Market Size
Table 2016-2026 Japan Remicade Biosimilar Market Size
Table 2016-2026 South Korea Remicade Biosimilar Market Size
Table 2016-2026 Southeast Asia Remicade Biosimilar Market Size
Table 2016-2026 Australia Remicade Biosimilar Market Size
Table 2016-2026 Europe Remicade Biosimilar Market Size
Figure 2016-2026 Europe Remicade Biosimilar Market Size and CAGR
Table 2016-2026 Europe Remicade Biosimilar Market Size by Application
Table 2016-2021 Europe Remicade Biosimilar Key Players Revenue
Table 2016-2021 Europe Remicade Biosimilar Key Players Market Share
Table 2016-2026 Europe Remicade Biosimilar Market Size by Type
Table 2016-2026 Germany Remicade Biosimilar Market Size
Table 2016-2026 France Remicade Biosimilar Market Size
Table 2016-2026 United Kingdom Remicade Biosimilar Market Size
Table 2016-2026 Italy Remicade Biosimilar Market Size
Table 2016-2026 Spain Remicade Biosimilar Market Size
Table 2016-2026 Belgium Remicade Biosimilar Market Size
Table 2016-2026 Netherlands Remicade Biosimilar Market Size
Table 2016-2026 Austria Remicade Biosimilar Market Size
Table 2016-2026 Poland Remicade Biosimilar Market Size
Table 2016-2026 Russia Remicade Biosimilar Market Size
Table 2016-2026 MEA Remicade Biosimilar Market Size
Figure 2016-2026 MEA Remicade Biosimilar Market Size and CAGR
Table 2016-2026 MEA Remicade Biosimilar Market Size by Application
Table 2016-2021 MEA Remicade Biosimilar Key Players Revenue
Table 2016-2021 MEA Remicade Biosimilar Key Players Market Share
Table 2016-2026 MEA Remicade Biosimilar Market Size by Type
Table 2016-2026 Egypt Remicade Biosimilar Market Size
Table 2016-2026 Israel Remicade Biosimilar Market Size
Table 2016-2026 South Africa Remicade Biosimilar Market Size
Table 2016-2026 Gulf Cooperation Council Countries Remicade Biosimilar Market Size
Table 2016-2026 Turkey Remicade Biosimilar Market Size
Table 2016-2021 Global Remicade Biosimilar Market Size by Region
Table 2016-2021 Global Remicade Biosimilar Market Size Share by Region
Table 2016-2021 Global Remicade Biosimilar Market Size by Application
Table 2016-2021 Global Remicade Biosimilar Market Share by Application
Table 2016-2021 Global Remicade Biosimilar Key Vendors Revenue
Figure 2016-2021 Global Remicade Biosimilar Market Size and Growth Rate
Table 2016-2021 Global Remicade Biosimilar Key Vendors Market Share
Table 2016-2021 Global Remicade Biosimilar Market Size by Type
Table 2016-2021 Global Remicade Biosimilar Market Share by Type
Table 2021-2026 Global Remicade Biosimilar Market Size by Region
Table 2021-2026 Global Remicade Biosimilar Market Size Share by Region
Table 2021-2026 Global Remicade Biosimilar Market Size by Application
Table 2021-2026 Global Remicade Biosimilar Market Share by Application
Table 2021-2026 Global Remicade Biosimilar Key Vendors Revenue
Figure 2021-2026 Global Remicade Biosimilar Market Size and Growth Rate
Table 2021-2026 Global Remicade Biosimilar Key Vendors Market Share
Table 2021-2026 Global Remicade Biosimilar Market Size by Type
Table 2021-2026 Remicade Biosimilar Global Market Share by Type
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Teva Pharmaceutical Industries
  • Synthon Pharmaceuticals
  • LG Life Sciences
  • Novartis (Sandoz)
  • Celltrion
  • Biocon
  • Hospira
  • Merck Serono (Merck Group)
  • Biogen idec Inc.
  • Genentech (Roche Group)
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll